Related Experiment Video
Updated: Jan 1, 2026
06:50
A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
Published on: September 16, 2022
3.5K
Antifungal activity against Candida biofilms
Melania Iñigo1, Javier Pemán, Jose L Del Pozo
1Department of Clinical Microbiology. Clínica Universidad de Navarra, Pamplona, Spain.
The International Journal of Artificial Organs
|November 10, 2012
Summary
Candida biofilms are resistant to antifungals, posing treatment challenges. Echinocandins and amphotericin B show promise against these resilient yeast communities.
Area of Science:
- Mycology
- Microbiology
- Infectious Diseases
Background:
- Candida species exist as planktonic cells or in resilient biofilms.
- Candida biofilms exhibit complex structures and are resistant to antifungal agents.
- Biofilm formation is a survival mechanism, increasing resistance to antifungals and stress.
Purpose of the Study:
- To review the challenges and therapeutic strategies for Candida biofilms.
- To highlight the efficacy of certain antifungals against Candida biofilms.
Main Methods:
- Literature review of Candida biofilm formation and antifungal resistance.
- Analysis of studies on antifungal activity against Candida biofilms.
Main Results:
- Azoles demonstrate limited efficacy against Candida biofilms.
- Echinocandins and amphotericin B show significant activity against Candida biofilms.
- Candida biofilm infections complicate foreign body-related infections.
Conclusions:
- Developing novel anti-fungal biofilm strategies is crucial due to increasing resistance.
- Understanding yeast's role in biofilms is key for new therapeutic approaches.
- Echinocandins and amphotericin B represent promising therapeutic options.
